Century Therapeutics

Century Therapeutics develops iPSC-derived cell therapies for cancer and inflammatory diseases.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series C
Initial Investment Year
2021
Century Portco Hover Image